SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001185185-18-001206
Filing Date
2018-07-02
Accepted
2018-07-02 17:00:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D sc13d_liu062818.htm SC 13D 40341
2 EX-99.1 ex99-1.htm EX-99.1 70501
  Complete submission text file 0001185185-18-001206.txt   112140
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Subject) CIK: 0001418133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85087 | Film No.: 18933525
SIC: 2834 Pharmaceutical Preparations

Mailing Address FLAT G, 14/F, BEGONIA MANSION 8 TAI KOO WAN ROAD TAI KOO SHING K3 00000000
Business Address
Liu Waiping (Filed by) CIK: 0001737327 (see all company filings)

Type: SC 13D